{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 3004"}, "official-title": {"#tail": "\n\t", "#text": "To promote the development of meaningful treatments for patients."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20141211", "#text": "December 11, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Hatch", "@name-id": "S118"}, "cosponsor": {"#tail": ") introduced the following bill; which was read twice and referred to the ", "#text": "Mr. Bennet", "@name-id": "S330"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Dormant Therapies Act of 2014", "@value": "Dormant Therapies Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n\t\t\t", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title"}, "#text": "\n\t\t\t", "@id": "HC44C6D0E9D004A4DB4A7BB3723965271", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The table of contents for this Act is as follows:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n\t\t\t", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Table of contents"}, "toc": {"#tail": "\n\t\t", "#text": "\n        ", "toc-entry": [{"@idref": "HC44C6D0E9D004A4DB4A7BB3723965271", "#tail": "\n\t\t\t\t", "#text": "Sec. 1. Short title.", "@level": "section"}, {"@idref": "H363FDF19068D401992C6D6CCA47B4DF0", "#tail": "\n\t\t\t\t", "#text": "Sec. 2. Table of contents.", "@level": "section"}, {"@idref": "H4E0FBFFB8BCA425FACE4D6155A2C40CE", "#tail": "\n\t\t\t\t", "#text": "Sec. 3. Definitions.", "@level": "section"}, {"@idref": "idAD9C2709E68D42338BEEC08F71174FED", "#tail": "\n\t\t\t\t", "#text": "Sec. 4. Capturing lost opportunities and creating new cures for patients.", "@level": "section"}, {"@idref": "idBCBE3C20EC6A4E41B4DEFFB0381D9ADE", "#tail": "\n\t\t\t", "#text": "Sec. 5. Implementation and effect.", "@level": "section"}]}, "#text": "\n\t\t\t", "@id": "H363FDF19068D401992C6D6CCA47B4DF0"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "In this Act:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n\t\t\t", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Definitions"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "term": {"#tail": " has the meaning given to that term in ", "#text": "biological product"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 262", "@value": "usc/42/262"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "idC288AB5C659C4C54AB43240798D1AB30", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Under Secretary of Commerce for Intellectual Property and Director of the United States\n\t\t\t Patent and Trademark Office", "@entity-id": "1344"}, "term": {"#tail": " means the ", "#text": "Director"}, "#text": "The term "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "id5611CF662B8347238CDCEB1A3CC13613", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 4(a)", "@value": "Dormant Therapies Act of 2014/s:4/ss:a", "@proposed": "true"}, "term": {"#tail": " means a medicine designated as a dormant therapy under ", "#text": "dormant therapy"}, "#text": "The term "}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "id2BEC1338125347668DB051B7D0BB8E5C", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "term": {"#tail": " has the meaning given to that term in ", "#text": "drug"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 201 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 321", "@value": "usc/21/321"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(4)"}, "@id": "H1DCE301FA3934C72B15D1E525BBBBAE5", "#text": "\n\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "term": {"#tail": " means a biological product or a drug.", "#text": "medicine"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(5)"}, "@id": "HC71FAA5D7CBB4F79BF6FAD0FE27D7F2D", "#text": "\n\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "term": {"#tail": ", with respect to a dormant therapy, means the period that\u2014", "#text": "protection period"}, "#text": "The term "}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "#text": "\n        ", "@id": "id1AD6CC0A08EC4C4395D92D00949147DD", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "begins on the date on which the Secretary first approves an application under ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " or ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section\n\t\t\t 505(b) of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(b)", "@value": "usc/21/355/b"}, "@parsable-cite": "usc/21/355", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": " for the dormant\n\t\t\t therapy for any indication; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 351(a)\n\t\t\t of the Public Health Service Act", "@value": "Public Health Service Act/s:351/ss:a"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 262(a)", "@value": "usc/42/262/a"}, "@parsable-cite": "usc/42/262", "#text": "\n              ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(A)"}, "@id": "idE722D57C555A414AB0795A803490D33E", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "ends on the date that is 15 years after the date of such approval."}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(B)"}, "@id": "id4293F6B81B5E4ABC9281412A67607776", "#text": "\n\t\t\t\t\t"}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "term": {"#tail": " means the ", "#text": "Secretary"}, "#text": "The term "}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(7)"}, "@id": "idB931CBD205004483ABBBC5C812948270", "#text": "\n\t\t\t\t"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "term": {"#tail": ", with respect to a dormant therapy, is the person who takes responsibility for the designation and\n\t\t\t development\n\t\t\t of the dormant therapy. The sponsor may be a single entity or an entity\n\t\t\t collaborating with one or more other entities.", "#text": "sponsor"}, "#text": "The term "}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "#text": "\n        ", "@id": "id399F0339B7304F27AF19DB0F5BC68725", "@commented": "no"}], "#text": "\n\t\t\t", "@id": "H4E0FBFFB8BCA425FACE4D6155A2C40CE"}, {"#tail": "\n    ", "enum": {"#tail": "\n\t\t\t", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Capturing lost opportunities and creating new cures for patients"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall designate a medicine as a dormant therapy if\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Designation as a dormant therapy"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the sponsor of the medicine submits a request for such designation meeting the requirements under\n\t\t\t subsection (b), and the request has not been withdrawn under subsection\n\t\t\t (d)(1); and"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "@id": "id455E6248EE19448690B150171E612975", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines that\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "#text": "\n\t\t\t\t\t", "@id": "id5440B08CD833465383C8910943B8CB55", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "the medicine is being investigated or is intended to be investigated for an indication to address\n\t\t\t one or more unmet medical needs;"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(A)"}, "@id": "idE17DEBABA94F4E25A34CEB0E7267BD25", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "a suitable clinical plan for such investigations of the medicine has been developed by the sponsor;"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(B)"}, "@id": "id37458C44A7F648FA963E0BDDE870ACB4", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "the sponsor intends to file an application pursuant to ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " or ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505(b) of the Federal Food, Drug,\n\t\t\t and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(b)", "@value": "usc/21/355/b"}, "@parsable-cite": "usc/21/355", "#text": "\n                ", "@legal-doc": "usc"}}, {"#tail": " for approval or licensing of the medicine\n\t\t\t for an indication described in subparagraph (A); and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 351(a) of the Public Health\n\t\t\t Service Act", "@value": "Public Health Service Act/s:351/ss:a"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 262(a)", "@value": "usc/42/262/a"}, "@parsable-cite": "usc/42/262", "#text": "\n                ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(C)"}, "@id": "id2B119B7A62034D458DD85D9F68AFD220", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "at the time the request for designation is made, the medicine for which designation is being\n\t\t\t requested contains,  in\n\t\t\t the case of a drug an active moiety that is not the same as, and in the\n\t\t\t case of a biological product an active moiety that is not highly\n\t\t\t similar to, an\n\t\t\t active moiety in a medicine for which an application under ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " or ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505 of\n\t\t\t the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 355", "@value": "usc/21/355"}, "@parsable-cite": "usc/21/355", "#text": "\n                ", "@legal-doc": "usc"}}, {"#tail": " has been submitted.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 351 of\n\t\t\t the Public Health Service Act", "@value": "Public Health Service Act/s:351"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 262", "@value": "usc/42/262"}, "@parsable-cite": "usc/42/262", "#text": "\n                ", "@legal-doc": "usc"}}], "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(D)"}, "@id": "id9B4BF83010B547069013072905068840", "#text": "\n\t\t\t\t\t\t"}]}], "#text": "\n\t\t\t\t", "@id": "id682F7D4CF8C0483180091837CE5AF2DE"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "A request under subsection (a)(1) with respect to a medicine may be made only by the sponsor of the\n\t\t\t medicine and shall contain each of the following:"}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Requirements for request for designation as dormant therapy"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "A listing of all United States patents and applications for patents under which the sponsor has\n\t\t\t rights and that\n\t\t\t may be reasonably construed to provide protection for the medicine."}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "@id": "idE67B53C86C14404F8BF9CE51CE564730", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "A waiver of patent rights to the extent required under subsection (c) to take effect, if at all, as\n\t\t\t provided under subsection (c)(3)."}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "@id": "idFEE884CD01484A5384169F8CF6ACA593", "#text": "\n\t\t\t\t\t"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may require by regulation in order to determine\n\t\t\t eligibility for designation under subsection (a).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Such additional information as the "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(3)"}, "@id": "id6E3CD0A8427743348F5656A9612FEDFD", "#text": "\n\t\t\t\t\t"}], "#text": "\n\t\t\t\t", "@id": "id019AD9A1A7AB44A1BF8C384DC4C136D9"}, {"#tail": "\n      ", "enum": {"#tail": "\n\t\t\t\t", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Waiver of patent rights expiring after the protection period ends"}, "paragraph": [{"#tail": "\n        ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "Subject to subparagraph (B), the request under this subsection shall include a waiver of the right\n\t\t\t to enforce or otherwise assert any patent described in subsection (b)(1)\n\t\t\t (or any patent issued on the basis of an application described in\n\t\t\t subsection (b)(1)), which may expire after the end of the protection\n\t\t\t period for the dormant therapy, against any applicable product described\n\t\t\t in paragraph (2). The waiver shall be made by the owner of the patent or\n\t\t\t application for patent, as the case may be.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "In general"}, "#text": "\n\t\t\t\t\t\t", "@id": "id8529105C9BDE44028CF4D7133E4082ED"}, {"#tail": "\n        ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "shall have no effect during the protection period for the medicine to which the waiver relates; and"}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(i)"}, "@id": "id7F724221EECD48B79ED109AB0057C8A8", "#text": "\n\t\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "shall have no effect with respect to the subject matter of a claimed invention in a patent that\n\t\t\t does not provide any protection for such medicine with respect to an\n\t\t\t applicable product described in paragraph (2)."}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(ii)"}, "@id": "idD10993E023F245E4917FF40F72BDC295", "#text": "\n\t\t\t\t\t\t\t"}], "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Limitations on patent waiver"}, "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Any patent waiver provided pursuant to this section, should it become effective\u2014"}, "#text": "\n\t\t\t\t\t\t", "@id": "id757F16925BFF4285B8B38C0607174956"}], "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Patent waiver"}, "#text": "\n\t\t\t\t\t", "@id": "idB01CB8DB67324257A2026EE7195F1A71"}, {"#tail": "\n        ", "@id": "idE1F5704450264B8F8DD1290F3C0E9E13", "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Applicable products described"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "An applicable product is described in this paragraph only if\u2014"}, "#text": "\n\t\t\t\t\t", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "it is approved or licensed pursuant to an application that\u2014"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(A)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 505(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b/p:2"}, {"#tail": " (", "@entity-type": "act", "#text": "505(j) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, {"#tail": ", ", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 355(b)(2)", "@value": "usc/21/355/b/2"}, {"#tail": ") or ", "@entity-type": "uscode", "#text": "(j)", "@value": "usc/21/355/j"}], "#text": "is filed under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 351(k) of the Public Health Service Act", "@value": "Public Health Service Act/s:351/ss:k"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42\n\t\t\t U.S.C. 262(k)", "@value": "usc/42/262/k"}], "@entity-type": "law-citation", "#text": "\n                  "}}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(i)"}, "@id": "id2C33692F808C4BE3BC01F4165210A6E3", "#text": "\n\t\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "references or otherwise relies upon the approval or licensure of the dormant therapy to which the\n\t\t\t waiver relates; and"}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(ii)"}, "@id": "idE7A4DFCEC3E04091867056C6CD7ED4AB", "#text": "\n\t\t\t\t\t\t\t"}], "#text": "\n\t\t\t\t\t\t", "@id": "id976750B34E5442D68B7D7DF6427C794C"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "the approval or licensure of the product occurs after the expiration of the protection period\n\t\t\t applicable to the\n\t\t\t medicine to which the request under subsection (a)(1) relates."}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(B)"}, "@id": "idFE52C20CA03E4F28BD264EDE4B6C767E", "#text": "\n\t\t\t\t\t\t"}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " publishes the notice required under subsection (e)(2)(F)\n\t\t\t relating to the patent.", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, "#text": "A waiver under subsection (b)(2) with respect to a patent shall take effect, if at all, on the date\n\t\t\t the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Effective date of waiver"}, "#text": "\n\t\t\t\t\t", "@id": "id60514ACA50DE4212A14A12335D049B1C"}], "#text": "\n\t\t\t\t", "@id": "id862A297243914E7A92EBEFB4949B23FF"}, {"#tail": "\n      ", "enum": {"#tail": "\n\t\t\t\t", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Withdrawal of request for designation, revocation by the secretary"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall deny a designation request or revoke any designation\n\t\t\t granted if at any time the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " finds that the sponsor is not in\n\t\t\t compliance with subsection (c)(1) or (g)(1).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The sponsor of a medicine may withdraw a request for designation under subsection (a)(1) with\n\t\t\t respect to a medicine unless the medicine has been approved or licensed\n\t\t\t under ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " or ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 505 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 355", "@value": "usc/21/355"}], "@entity-type": "law-citation", "#text": "\n              "}, {"#tail": ". The\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 262", "@value": "usc/42/262"}, "@parsable-cite": "usc/42/262", "#text": "\n              ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "In general"}, "#text": "\n\t\t\t\t\t", "@id": "idEA15EC979D8F4EEEAD1D9EFAA693F4FF"}, {"#tail": "\n        ", "@id": "idCDB78B64F07B42A2993C54A827FB5042", "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Effects of withdrawal of request or revocation of designation"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " denies a\n\t\t\t designation request or revokes a designation with respect to the medicine\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the sponsor of a medicine withdraws a request under subsection (b) or the "}, "#text": "\n\t\t\t\t\t", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "any patent waiver submitted under this section with respect to the medicine, but not yet effective,\n\t\t\t is canceled and deemed a nullity;"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(A)"}, "@id": "idC1483793644B490B818103A8FF3608C5", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "any patent waiver that has taken effect under this section with respect to the medicine shall\n\t\t\t remain in effect;"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(B)"}, "@id": "id7A2F10DC0D2D43BA9122AD995B3422FB", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under subsection (e)(2) with respect to the\n\t\t\t medicine shall be canceled, except that the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": " shall maintain the\n\t\t\t patent term extension for one patent, to be selected by the sponsor of the\n\t\t\t medicine, for the period of extension that would have been applicable\n\t\t\t under ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": "; and", "@entity-type": "uscode", "#text": "\n                ", "external-xref": {"#tail": " of title 35, United States Code", "@parsable-cite": "usc/35/156", "#text": "section 156", "@legal-doc": "usc"}, "@value": "usc/35/156"}], "#text": "any patent term extension granted by the "}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(C)"}, "@id": "id3ED820355A1049B181C6B5E52F1FF901", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "the designation, if made, otherwise shall be treated as never having been requested or made or\n\t\t\t having effect."}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(D)"}, "@id": "id6D88EB4EFBEA4AAB838F0CC5A113AB5F", "#text": "\n\t\t\t\t\t\t"}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may revoke a designation made under subsection (a), but only based upon a finding by\n\t\t\t the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " under paragraph (1).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Basis for revocation"}, "#text": "\n\t\t\t\t\t", "@id": "idA3F3FE60C2C14C749E5DED404AA613EA"}], "#text": "\n\t\t\t\t", "@id": "id4BE066A7F9CD447BA13489FD105955FF"}, {"#tail": "\n      ", "enum": {"#tail": "\n\t\t\t\t", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Guaranteed protections for dormant therapies"}, "paragraph": [{"#tail": "\n        ", "@id": "id388D30EC9B594EAA8B3E0D9F37BA0C96", "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Applications filed during the protection period"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "During the protection period for a dormant therapy, notwithstanding any other provision of the\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " or the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et seq.", "@value": "usc/21/301/etseq"}, "@parsable-cite": "usc/21/301", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": "\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Public\n\t\t\t Health Service Act", "@value": "Public Health Service Act"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 201 et seq.", "@value": "usc/42/201/etseq"}, "@parsable-cite": "usc/42/201", "#text": "\n              ", "@legal-doc": "usc"}}]}, "#text": "\n\t\t\t\t\t", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section\n\t\t\t 505(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b/p:2"}, {"#tail": "\n\t\t\t (", "@entity-type": "act", "#text": "section 505(j) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, {"#tail": ") or ", "@entity-type": "uscode", "#text": "(j)", "@value": "usc/21/355/j"}], "#text": "absent a right of reference from the holder of such approved application for the\n\t\t\t dormant therapy,\n\t\t\t the Secretary shall not approve an application filed pursuant to ", "external-xref": {"#tail": ", ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(b)(2)", "@value": "usc/21/355/b/2"}, "@parsable-cite": "usc/21/355", "#text": "\n                ", "@legal-doc": "usc"}, "{http://namespaces.cato.org/catoxml}entity": {"#tail": " referencing or otherwise relying on the approval of\n\t\t\t the dormant therapy;", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 351(k) of the Public Health Service\n\t\t\t Act", "@value": "Public Health Service Act/s:351/ss:k"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 262(k)", "@value": "usc/42/262/k"}, "@parsable-cite": "usc/42/262", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(A)"}, "@id": "id75B877A35F3842DD9A6D3A8C3F757B96", "#text": "\n\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the Secretary shall not approve\u2014"}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(B)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 505(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b/p:2"}, {"#tail": " that references or otherwise\n\t\t\t relies on the approval of a medicine that is not the dormant\n\t\t\t therapy, was approved subsequent to the approval of the dormant therapy,\n\t\t\t and contains the same active moiety as the active moiety in the dormant\n\t\t\t therapy (or if the dormant therapy contains more than one active moiety,\n\t\t\t all of the active moieties are the same); or", "@entity-type": "act", "#text": "505(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}], "#text": "an application filed pursuant to such ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(i)"}, "@id": "idC6A9670C129044A1B9C0107DD544764E", "#text": "\n\t\t\t\t\t\t\t"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that references or otherwise relies on the\n\t\t\t licensure of a medicine that is not the dormant therapy, was\n\t\t\t licensed subsequent to the licensure of the dormant therapy,\n\t\t\t and contains an active moiety that is highly similar to the active moiety\n\t\t\t in the dormant therapy (or if the dormant therapy contains more than one\n\t\t\t active moiety, all of the active moieties are highly similar); and", "@entity-type": "act", "#text": "section 351(k)", "@value": "Public Health Service Act/s:351/ss:k"}, "#text": "an application filed pursuant to such ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(ii)"}, "@id": "id40D3773456C549AC9FEF295ABEB4E77D", "#text": "\n\t\t\t\t\t\t\t"}], "#text": "\n\t\t\t\t\t\t", "@id": "idB9C0D0023EC146B995C93CAB4860B56B"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall not approve an application filed pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " for a drug that\n\t\t\t contains the same active moiety as the active moiety in the qualifying\n\t\t\t medicine (or if the qualifying medicine contains more than one active\n\t\t\t moiety, all of the active moieties are the same), or an application filed\n\t\t\t pursuant to ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505(b)(1) of the Federal\n\t\t\t Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b/p:1"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(b)(1)", "@value": "usc/21/355/b/1"}, "@parsable-cite": "usc/21/355", "#text": "\n                ", "@legal-doc": "usc"}}, {"#tail": " for a biological product that contains an active moiety that is\n\t\t\t highly similar to the active moiety in the qualifying medicine (or if the\n\t\t\t qualifying medicine contains more than one active moiety, all of the\n\t\t\t active moieties are highly similar), unless the information provided to\n\t\t\t support approval of such application is comparable in scope and extent,\n\t\t\t including with respect to design and extent of preclinical and clinical\n\t\t\t testing, to the information provided to support approval of the\n\t\t\t application for the qualifying medicine under ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 351(a) of the Public Health Service Act", "@value": "Public Health Service Act/s:351/ss:a"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 262(a)", "@value": "usc/42/262/a"}], "@entity-type": "law-citation", "#text": "\n                "}, {"#tail": " or ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505(b) of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(b)", "@value": "usc/21/355/b"}, "@parsable-cite": "usc/21/355", "#text": "\n                ", "@legal-doc": "usc"}}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 351(a)\n\t\t\t of the Public Health Service Act", "@value": "Public Health Service Act/s:351/ss:a"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 262(a)", "@value": "usc/42/262/a"}, "@parsable-cite": "usc/42/262", "#text": "\n                ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "id666EB57EFB384052AC901E67FB4DB73C", "#text": "\n            "}]}, {"#tail": "\n      ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", a sponsor of a medicine designated\n\t\t\t as a dormant therapy under subsection (a)(1), upon the approval or\n\t\t\t licensure thereof under ", "@entity-type": "uscode", "#text": "title 35, United States Code", "@value": "usc/35"}, {"#tail": ", shall be entitled to\n\t\t\t patent term extensions in accordance with this paragraph.", "@entity-type": "uscode", "#text": "section 156(d) of such title 35", "@value": "usc/35/156/d"}], "#text": "Notwithstanding any provision of ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " or ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 355", "@value": "usc/21/355"}, "@parsable-cite": "usc/21/355", "#text": "\n                ", "@legal-doc": "usc"}}, {"#tail": ", and in lieu of filing a patent term extension\n\t\t\t application under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 351 of the Public Health Service\n\t\t\t Act", "@value": "Public Health Service Act/s:351"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 262", "@value": "usc/42/262"}, "@parsable-cite": "usc/42/262", "#text": "\n                ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "In general"}, "#text": "\n\t\t\t\t\t\t", "@id": "idB0448D01AD1B4BB085B6751CE56AF686"}, {"#tail": "\n          ", "clause": [{"#tail": "\n            ", "subclause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " under subsection\n\t\t\t (b)(1);", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the listing of patents and applications for patents provided to the "}, "enum": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "(I)"}, "@id": "idA9B29F95B7D44B0495662FDDD68147E3", "#text": "\n\t\t\t\t\t\t\t\t"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "any revisions to such listing as may be required for compliance with subsection (b)(1); and"}, "enum": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "(II)"}, "@id": "id317E61255AD84187A32FB212EBD96C1E", "#text": "\n\t\t\t\t\t\t\t\t"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may require from the patentee or patent applicant (as the case may\n\t\t\t be) of the waiver of patent rights required under subsection (b)(2).", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, "#text": "any documentation the "}, "enum": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "(III)"}, "@id": "id6139651244B74DF1BCCEFC1A05BE6006", "#text": "\n\t\t\t\t\t\t\t\t"}], "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Submission"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of not less than 2\n\t\t\t months beginning on the date the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": " approves or licenses the\n\t\t\t dormant therapy, shall submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}], "#text": "The sponsor of the dormant therapy, within a period to be set by the "}, "#text": "\n\t\t\t\t\t\t\t", "@id": "idE179C080FD6D4B38ABEEDDF472EE2D1E"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " determines that the sponsor has not complied with the waiver requirements under\n\t\t\t subsection (c), after providing the sponsor the opportunity to remedy any\n\t\t\t insufficiency, the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": " shall so notify the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": " that the patent\n\t\t\t waiver requirements for designation have not been satisfied.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If the "}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(ii)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Failure to provide sufficient documentation of waiver"}, "#text": "\n\t\t\t\t\t\t\t", "@id": "id485F1C2EC2EB4F2FA51740C68353A0C4"}], "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Submission of final listing of patents and applications for patents following approval or licensure"}, "#text": "\n\t\t\t\t\t\t", "@id": "idDA7FD53F0CB9441289FDEAFAB038775F"}, {"#tail": "\n          ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " has notified the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": " of a determination under subparagraph (B)(ii), for\n\t\t\t each patent identified in a submission pursuant to subparagraph (B)(i),\n\t\t\t and for each patent issuing based upon an application for patent so\n\t\t\t identified, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall, within the 3-month period beginning on the\n\t\t\t date of the submission, extend the patent to expire at the end of the\n\t\t\t protection period for the dormant therapy, if the patent would otherwise\n\t\t\t expire before the end of the protection period. If the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": " has so\n\t\t\t notified the ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": " under subparagraph (B)(ii), the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall\n\t\t\t extend one such patent, selected by the sponsor, for the period that would\n\t\t\t have been applicable had an application for extension been filed under\n\t\t\t ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": ", with respect to such patent.", "@entity-type": "uscode", "#text": "\n                  ", "external-xref": {"#tail": " of title 35, United States Code", "@parsable-cite": "usc/35/156", "#text": "section 156", "@legal-doc": "usc"}, "@value": "usc/35/156"}], "#text": "Unless the "}, "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In general"}, "#text": "\n\t\t\t\t\t\t\t", "@id": "id8C8FB35EC8F34745A94A1D043204F302"}, {"#tail": "\n          ", "subclause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "uscode", "#text": "section 156(b) of title\n\t\t\t 35, United States Code", "@value": "usc/35/156/b"}, "#text": "the rights under the patent shall be limited in the manner provided under "}, "enum": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "(I)"}, "@id": "id45D4AD2D538D4880A84E38BB196F4200", "#text": "\n\t\t\t\t\t\t\t\t"}, {"#tail": "\n            ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be deemed to include forms of the active moiety of the dormant\n\t\t\t therapy and highly similar active moieties that might be approved or\n\t\t\t licensed by the\n\t\t\t ", "@entity-type": "uscode", "#text": "section 156(b)", "@value": "usc/35/156/b"}, {"#tail": " based upon an application filed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or\n\t\t\t ", "@entity-type": "act", "#text": "section 505(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b/p:2"}, {"#tail": " (", "@entity-type": "act", "#text": "505(j) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, {"#tail": ") or under ", "@entity-type": "uscode", "#text": "(j)", "@value": "usc/21/355/j"}], "#tail": "\n\t\t\t\t\t\t\t", "quote": [{"#tail": " and ", "#text": "product"}, {"#tail": " in such ", "#text": "approved product"}], "external-xref": {"#tail": ",\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(b)(2)", "@value": "usc/21/355/b/2"}, "@parsable-cite": "usc/21/355", "#text": "\n                    ", "@legal-doc": "usc"}, "{http://namespaces.cato.org/catoxml}entity": {"#tail": " that references or otherwise relies upon the dormant therapy.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 351(k) of the Public Health Service Act", "@value": "Public Health Service Act/s:351/ss:k"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 262(k)", "@value": "usc/42/262/k"}], "@entity-type": "law-citation", "#text": "\n                    "}, "#text": "the terms "}, "enum": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "(II)"}, "@id": "id8D7E3119498B4AE4B61BFA73610350CB", "#text": "\n\t\t\t\t\t\t\t\t"}], "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(ii)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Application of certain provisions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "During the period of an extension under clause (i)\u2014"}, "#text": "\n\t\t\t\t\t\t\t", "@id": "idFC7203A2FCEE4110971F9780F33C3EA2"}], "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Extension of patents"}, "#text": "\n\t\t\t\t\t\t", "@id": "id26DCE8E255CC4C9D9159ADAD2426CF13"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", with respect to any patent listed\n\t\t\t (or patent issuing on an application listed) under subsection (b)(1) that\n\t\t\t would otherwise expire before the sponsor could make a submission under\n\t\t\t subparagraph (B), the ", "@entity-type": "uscode", "#text": "title 35, United States Code", "@value": "usc/35"}, {"#tail": ", upon application of the patentee, shall\n\t\t\t grant to the patentee an interim extension of such patent, subject to the\n\t\t\t limitations in ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": ", for such period as\n\t\t\t may be necessary to permit the sponsor to submit the listing under\n\t\t\t subparagraph (B) and, if the patent is therein listed, to extend the\n\t\t\t patent as provided under subparagraph (C). The ", "@entity-type": "uscode", "#text": "section 156(d)(5)(F) of such title 35", "@value": "usc/35/156/d/5/F"}, {"#tail": " may require, for\n\t\t\t any patent extended under this subparagraph, that the sponsor of the\n\t\t\t dormant therapy to which the patent relates provide periodic\n\t\t\t certifications that development of the dormant therapy is continuing. The\n\t\t\t ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": " may terminate any interim extension for which a required\n\t\t\t certification has not been made.", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}], "#text": "Notwithstanding any provision of "}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(D)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Interim patent extensions"}, "#text": "\n\t\t\t\t\t\t", "@id": "id9E8117920D504550BFC7976A93CB12CF"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall publish a notice of such\n\t\t\t extension and issue a certificate of extension described in ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, {"#tail": ".", "@entity-type": "uscode", "#text": "section\n\t\t\t 156(e)(1) of title 35, United States Code", "@value": "usc/35/156/e/1"}], "#text": "For each patent that is extended under this paragraph, the "}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(E)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Notice of extension"}, "#text": "\n\t\t\t\t\t\t", "@id": "idD7C8FC1E72494A4CA5052542ABFB97E7"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t publish a notice that the patent is subject to the limited waiver of the\n\t\t\t right to enforce described in subsection (c)(1).", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1344"}, "#text": "For each patent identified in a submission under subparagraph (B)(i), and each patent issuing based\n\t\t\t upon an application for patent so identified, that expires after the end\n\t\t\t of the protection period for the dormant therapy, the "}, "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(F)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Notice of waiver"}, "#text": "\n\t\t\t\t\t\t", "@id": "id392355063DE34AB2B73DA188DDD1E0FA"}], "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Patent term alignment with data package protection period"}, "#text": "\n\t\t\t\t\t", "@id": "id4AB9B278086240819204FD4C95A2636A"}], "#text": "\n\t\t\t\t", "@id": "id820A4C9E4A784B8AB9DA564AEC46AC98"}, {"#tail": "\n      ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t ", "@entity-type": "act", "#text": "sections 505A", "@value": "Federal Food, Drug, and Cosmetic Act/s:505A"}, {"#tail": ", and ", "@entity-type": "act", "#text": "505E", "@value": "Federal Food, Drug, and Cosmetic Act/s:505E"}, {"#tail": " (", "@entity-type": "act", "#text": "527 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:527"}, {"#tail": ", ", "@entity-type": "uscode", "#text": "355f", "@value": "usc/21/355f"}, {"#tail": ") shall not apply. The preceding sentence shall not be\n\t\t\t construed to affect any protections applicable with respect to a medicine,\n\t\t\t including a medicine designated under ", "@entity-type": "uscode", "#text": "360cc", "@value": "usc/21/360cc"}, {"#tail": ", ", "@entity-type": "act", "#text": "sections 505A", "@value": "Federal Food, Drug, and Cosmetic Act/s:505A"}, {"#tail": ", and ", "@entity-type": "act", "#text": "505E", "@value": "Federal Food, Drug, and Cosmetic Act/s:505E"}, {"#tail": ".", "@entity-type": "act", "#text": "527", "@value": "Federal Food, Drug, and Cosmetic Act/s:527"}], "#tail": "\n\t\t\t", "external-xref": {"#tail": ",\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 355a", "@value": "usc/21/355a"}, "@parsable-cite": "usc/21/355a", "#text": "\n            ", "@legal-doc": "usc"}, "{http://namespaces.cato.org/catoxml}entity": {"#tail": " for a rare disease or condition, under provisions other than such\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 526 of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:526"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 360bb", "@value": "usc/21/360bb"}], "@entity-type": "law-citation", "#text": "\n            "}, "@display-inline": "yes-display-inline", "#text": "If a medicine has been designated as a dormant therapy under subsection (a), the protections\n\t\t\t otherwise applicable with respect to such medicine under "}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Certain FDA protections inapplicable"}, "#text": "\n\t\t\t\t", "@id": "idD6B97943855B45A5AA9C3D2036751F81"}, {"#tail": "\n      ", "enum": {"#tail": "\n\t\t\t\t", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Development certifications"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall require that the sponsor of a dormant therapy provide a certification that the\n\t\t\t clinical plan under subsection (a)(2)(B) has been completed, and, that the\n\t\t\t initial marketing approval or licensure for the qualifying medicine was\n\t\t\t based on the investigations set forth in such clinical plan (including\n\t\t\t modifications to the initial plan approved by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "). Prior to receiving such certifications, the ", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t Administration", "@entity-id": "7524"}, {"#tail": "\n\t\t\t shall require periodic certifications that the clinical plan under\n\t\t\t subsection (a)(2)(B) is continuing.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "In general"}, "#text": "\n\t\t\t\t\t", "@id": "id44459C9D1A4A4FD3B016550C1773F5EE", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " concludes that the sponsor has not complied with paragraph (1), after providing\n\t\t\t the sponsor the opportunity to remedy any insufficiency, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t shall, for purposes of subsection (d)(1), determine that the sponsor is\n\t\t\t not in compliance with the certification requirement under paragraph (1).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If the "}, "enum": {"#tail": "\n\t\t\t\t\t", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Determination of noncompliance"}, "#text": "\n\t\t\t\t\t", "@id": "id82EA494CD02A4BAD86128C7F5FB488F1", "@commented": "no"}], "#text": "\n\t\t\t\t", "@id": "idBEA8FDDC760F44038D055FD34E4AFE18", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Nothing in this section shall be construed as preventing a sponsor from collaborating with other\n\t\t\t entities in developing a dormant therapy or applying for a dormant therapy\n\t\t\t designation."}, "enum": {"#tail": "\n\t\t\t\t", "#text": "(h)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Collaboration"}, "#text": "\n\t\t\t\t", "@id": "idFE2998643FEC4335939EAD0C129F4AE5", "@commented": "no"}], "#text": "\n\t\t\t", "@id": "idAD9C2709E68D42338BEEC08F71174FED"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "Implementation and effect"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Subject to the provisions of this section, this Act shall take effect on the date of enactment."}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Effective date"}, "#text": "\n        ", "@id": "id8033ee5876c74c5488ebfb0734714601"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in consultation with the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall promulgate such regulations\n\t\t\t and finalize such guidance as necessary to implement the provisions of\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary of Commerce", "@entity-id": "1300"}, {"#tail": ". Such regulations or guidance shall take effect 18 months\n\t\t\t after the date of enactment of this Act.", "@entity-type": "act", "#text": "section 4", "@value": "Dormant Therapies Act of 2014/s:4", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Implementing regulations"}, "#text": "\n        ", "@id": "ida11114a53eed4ecd8c90459f56e4ec15"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "section 4", "@value": "Dormant Therapies Act of 2014/s:4", "@proposed": "true"}, {"#tail": " may not make a determination on a request\n\t\t\t for designation by a manufacturer or sponsor under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " prior to\n\t\t\t the effective date of the regulations under subsection (b) or 30 months\n\t\t\t after the date of enactment of this Act, whichever occurs first, and the\n\t\t\t ", "@entity-type": "act", "#text": "section 4(a)", "@value": "Dormant Therapies Act of 2014/s:4/ss:a", "@proposed": "true"}, {"#tail": " may not designate a medicine under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " unless the\n\t\t\t requirement under ", "@entity-type": "act", "#text": "section 4(a)", "@value": "Dormant Therapies Act of 2014/s:4/ss:a", "@proposed": "true"}, {"#tail": " is met for such medicine as of the\n\t\t\t effective date of the regulations under subsection (b) or 30 months after\n\t\t\t the date of enactment of this Act, whichever occurs first.", "@entity-type": "act", "#text": "section 4(a)(2)(D)", "@value": "Dormant Therapies Act of 2014/s:4/ss:a/p:2/sp:D", "@proposed": "true"}], "#text": "Notwithstanding any provision of "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Limitation on determinations and designations"}, "#text": "\n        ", "@id": "idc3da9f738ab54e1c81b8e05c8340f436"}], "#text": "\n      ", "@id": "idBCBE3C20EC6A4E41B4DEFFB0381D9ADE"}], "#text": "\n\t\t", "@id": "HC36741CED0E84E1ABEC6FA02F990610B"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-12-11"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S3004 IS: Dormant Therapies Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}